Maurício Schüler Nin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maurício Schüler Nin has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Felipe Borges Almeida
Graduate Program in Health Sciences Federal University of Health Sciences of Porto Alegre (UFCSPA) Porto Alegre Brazil
2 shared publications - Helena Maria Tannhauser Barros
Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil; Department of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil
2 shared publications - Rianne Remus Pulcinelli
Programa de Pós-graduação em Farmacologia e Terapêutica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
2 shared publications - Rosane Gomez
Programa de Pós-graduação em Farmacologia e Terapêutica, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
2 shared publications - Solange Bandiera
Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
2 shared publications - Alcindo Antônio Ferla
Universidade Federal do Rio Grande do Sul
1 shared publication
Latest Publications
- Open Access
- 4 May 2026
- Published by Associacao Brasileira da Rede Unida in Saúde em Redes
- Vol. 12 (2) , 5139
Desigualdades regionais, informalidade e a distribuição dos Conselhos Locais de Saúde no Brasil: evidências do segundo ciclo do PMAQ-AB
Objetivo: Descrever a distribuição da Participação da Comunidade na Atenção Básica no Brasil. Método: Estudo transversal quantitativo, utilizando o banco de dados da avaliação externa respondida por equipes de saúde da família, saúde bucal e usuários de Unidades de Saúde participantes do Segundo Ciclo do Programa Nacional de Melhoria do Acesso e da Qualidade da Atenção Básica (PMAQ-AB). Extraiu-se o banco de dados público. Organizaram-se as respostas das equipes e dos usuários sobre a existência de Conselhos Locais de Saúde (CLS) em três categorias distintas. Trataram-se os dados organizando por estratos de região do Brasil e tipos de cidade. Foi aplicada estatística descritiva, com frequências absoluta e relativa. Resultados: Participaram do Segundo Ciclo do PMAQ-AB 30.523 equipes, correspondendo a 41,51% do total, das quais 29.778 (97,56%) responderam a avaliação externa e 114.615 usuários de 5.042 municípios. Entre as equipes, a existência de CLS com documento de registro foi de 33,20%, a existência de CLS sem documento, 23,39%, e a não existência de CLS, 43,41%. Entre os usuários, os que sabiam da existência de CLS eram 20,03%, os que sabiam que não existia CLS em sua US somavam 31,21%, e os que não souberam responder foram 48,70%. A distribuição não foi uniforme entre as regiões e tipos de cidades. Conclusões: A presença de CLS ou instância equivalente ainda não é uma realidade em grande parte das equipes participantes do segundo ciclo do PMAQ-AB, excetuando as capitais do Sul e Sudeste. O desconhecimento dos usuários sobre esses arranjos é prevalente em todas as regiões do Brasil.
- 4 May 2026
- Published by Associacao Brasileira da Rede Unida in Saúde em Redes
- Vol. 12 (2) , 5139
Open AccessDesigualdades regionais, informalidade e a distribuição dos Conselhos Locais de Saúde no Brasil: evidências do segundo ciclo do PMAQ-AB
Objetivo: Descrever a distribuição da Participação da Comunidade na Atenção Básica no Brasil. Método: Estudo transversal quantitativo, utilizando o banco de dados da avaliação externa respondida por equipes de saúde da família, saúde bucal e usuários de Unidades de Saúde participantes do Segundo Ciclo do Programa Nacional de Melhoria do Acesso e da Qualidade da Atenção Básica (PMAQ-AB). Extraiu-se o banco de dados público. Organizaram-se as respostas das equipes e dos usuários sobre a existência de Conselhos Locais de Saúde (CLS) em três categorias distintas. Trataram-se os dados organizando por estratos de região do Brasil e tipos de cidade. Foi aplicada estatística descritiva, com frequências absoluta e relativa. Resultados: Participaram do Segundo Ciclo do PMAQ-AB 30.523 equipes, correspondendo a 41,51% do total, das quais 29.778 (97,56%) responderam a avaliação externa e 114.615 usuários de 5.042 municípios. Entre as equipes, a existência de CLS com documento de registro foi de 33,20%, a existência de CLS sem documento, 23,39%, e a não existência de CLS, 43,41%. Entre os usuários, os que sabiam da existência de CLS eram 20,03%, os que sabiam que não existia CLS em sua US somavam 31,21%, e os que não souberam responder foram 48,70%. A distribuição não foi uniforme entre as regiões e tipos de cidades. Conclusões: A presença de CLS ou instância equivalente ainda não é uma realidade em grande parte das equipes participantes do segundo ciclo do PMAQ-AB, excetuando as capitais do Sul e Sudeste. O desconhecimento dos usuários sobre esses arranjos é prevalente em todas as regiões do Brasil.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Acta Amazonica
- Vol. 52 (1) , 53-59
Copaiba (Copaifera reticulata) oleoresin reduces voluntary alcohol intake in rats
Copaiba oleoresin, extracted from the Copaifera reticulata tree, has been used as a remedy in popular medicine in the Brazilian Amazon for various purposes, including reducing drug abuse. Yet no studies evaluated the effect of repeated administration of copaiba oil on alcohol consumption in animals. To evaluate this effect, we divided adult male Wistar rats into a) an alcohol group in which the animals had free access to choose between two bottles: one containing alcohol solution (20%) and another containing vehicle solution (0.2% saccharin); and b) a control group with access to two bottles containing vehicle solution. Rats were free to drink 24 h per day, for 35 days. Daily alcohol consumption and weekly body weight gain and food intake were monitored. From day 22, half of the rats in each group received 600 mg kg-1 copaiba oleoresin and the other received vehicle, subcutaneously, once a day, for three days. On day 35, rats were evaluated in an open-field test. The results showed that copaiba oil decreased voluntary alcohol intake and preference between days 2 and 6 after the last administration. Copaiba treatment also decreased the food intake and body weight gain in both alcohol and control groups without changing behaviors in the open-field test. Therefore, copaiba oil was able to reduce voluntary alcohol consumption in rats and could be tested in humans as an adjuvant to treat alcohol use disorder.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Acta Amazonica
- Vol. 52 (1) , 53-59
Open AccessCopaiba (Copaifera reticulata) oleoresin reduces voluntary alcohol intake in rats
Copaiba oleoresin, extracted from the Copaifera reticulata tree, has been used as a remedy in popular medicine in the Brazilian Amazon for various purposes, including reducing drug abuse. Yet no studies evaluated the effect of repeated administration of copaiba oil on alcohol consumption in animals. To evaluate this effect, we divided adult male Wistar rats into a) an alcohol group in which the animals had free access to choose between two bottles: one containing alcohol solution (20%) and another containing vehicle solution (0.2% saccharin); and b) a control group with access to two bottles containing vehicle solution. Rats were free to drink 24 h per day, for 35 days. Daily alcohol consumption and weekly body weight gain and food intake were monitored. From day 22, half of the rats in each group received 600 mg kg-1 copaiba oleoresin and the other received vehicle, subcutaneously, once a day, for three days. On day 35, rats were evaluated in an open-field test. The results showed that copaiba oil decreased voluntary alcohol intake and preference between days 2 and 6 after the last administration. Copaiba treatment also decreased the food intake and body weight gain in both alcohol and control groups without changing behaviors in the open-field test. Therefore, copaiba oil was able to reduce voluntary alcohol consumption in rats and could be tested in humans as an adjuvant to treat alcohol use disorder.
- 13 August 2020
- Published by Springer Nature in Toxicological Research
- Vol. 37 (2) , 209-219
Hepatic and renal damage by alcohol and cigarette smoking in rats
Chronic use of alcohol and tobacco cigarettes is associated to millions of deaths per year, either by direct or indirect causes. However, few studies have explored the additional risks of the combined use of these drugs. Here we assessed the effect of the combined use of alcohol and cigarette smoke on liver or kidney morphology, and on biochemical parameters in chronically treated rats. Male Wistar rats were allocated to receive 2 g/kg alcohol orally, which was followed by the inhalation of smoke from six cigarettes during 2 h (ALTB group) for 28 days. Other groups received alcohol alone (AL) or were exposed to cigarette smoke (TB) alone and were compared to control (CT) rats, which received water followed by ambient air. On day 29, rats were euthanized and blood samples were collected for aminotransferase enzymes (AST and ALT), creatinine, and urea analysis. Liver and kidney were weighted, dissected, fixed, and stained with hematoxylin and eosin for morphological analysis. Our results showed that necrosis was elevated in the AL, TB, and mainly the ALTB group in both liver and kidney of rats. Serum levels of AST and ALT were reduced by cigarette smoke exposure, independently of alcohol use. Serum creatinine levels increased after tobacco smoke exposure. On the other hand, TB and AL groups decreased serum urea levels, and their association restored that decrease. Absolute liver and kidney weights were lower in the cigarette smoke exposure rats. Lastly, body weight gain was lower in TB group and combined use restored it. Thus, we may infer that the use of alcohol, exposure to tobacco cigarette smoke or, mainly, their association promotes liver and kidney injuries, and this damage is related with biochemical changes in rats.
- 13 August 2020
- Published by Springer Nature in Toxicological Research
- Vol. 37 (2) , 209-219
Hepatic and renal damage by alcohol and cigarette smoking in rats
Chronic use of alcohol and tobacco cigarettes is associated to millions of deaths per year, either by direct or indirect causes. However, few studies have explored the additional risks of the combined use of these drugs. Here we assessed the effect of the combined use of alcohol and cigarette smoke on liver or kidney morphology, and on biochemical parameters in chronically treated rats. Male Wistar rats were allocated to receive 2 g/kg alcohol orally, which was followed by the inhalation of smoke from six cigarettes during 2 h (ALTB group) for 28 days. Other groups received alcohol alone (AL) or were exposed to cigarette smoke (TB) alone and were compared to control (CT) rats, which received water followed by ambient air. On day 29, rats were euthanized and blood samples were collected for aminotransferase enzymes (AST and ALT), creatinine, and urea analysis. Liver and kidney were weighted, dissected, fixed, and stained with hematoxylin and eosin for morphological analysis. Our results showed that necrosis was elevated in the AL, TB, and mainly the ALTB group in both liver and kidney of rats. Serum levels of AST and ALT were reduced by cigarette smoke exposure, independently of alcohol use. Serum creatinine levels increased after tobacco smoke exposure. On the other hand, TB and AL groups decreased serum urea levels, and their association restored that decrease. Absolute liver and kidney weights were lower in the cigarette smoke exposure rats. Lastly, body weight gain was lower in TB group and combined use restored it. Thus, we may infer that the use of alcohol, exposure to tobacco cigarette smoke or, mainly, their association promotes liver and kidney injuries, and this damage is related with biochemical changes in rats.
- 2 August 2015
- Published by Springer Nature in Psychopharmacology
- Vol. 232 (19) , 3623-3636
Brain DNA damage and behavioral changes after repeated intermittent acute ethanol withdrawal by young rats
Alcohol addiction causes severe problems, and its deprivation may potentiate symptoms such as anxiety. Furthermore, ethanol is a neurotoxic agent that induces degeneration and the consequences underlying alcohol-mediated brain damage remain unclear. This study assessed the behavioral changes during acute ethanol withdrawal periods and determined the levels of DNA damage and reactive oxygen species (ROS) in multiple brain areas. Male Wistar rats were subjected to an oral ethanol self-administration procedure with a forced diet where they were offered 8 % (v/v) ethanol solution for 21 days followed by five repeated 24-h cycles alternating between ethanol withdrawal and re-exposure. Control animals received an isocaloric control diet without ethanol. Behavioral changes were analyzed on ethanol withdrawal days in the open-field (OF) and elevated plus-maze (EPM) tests within the first 6 h of ethanol deprivation. The pre-frontal cortex, hypothalamus, striatum, hippocampus, and cerebellum were dissected for alkaline and neutral comet assays and for dichlorofluorescein ROS testing. The repeated intermittent ethanol access enhanced solution intake and alcohol-seeking behavior. Decreased exploratory activity was observed in the OF test, and the animals stretched less in the EPM test. DNA single-strand breaks and ROS production were significantly higher in all structures evaluated in the ethanol-treated rats compared with controls. The animal model of repeated intermittent ethanol access induced behavioral changes in rats, and this ethanol exposure model induced an increase in DNA single-strand breaks and ROS production in all brain areas. Our results suggest that these brain damages may influence future behaviors.
- 2 August 2015
- Published by Springer Nature in Psychopharmacology
- Vol. 232 (19) , 3623-3636
Brain DNA damage and behavioral changes after repeated intermittent acute ethanol withdrawal by young rats
Alcohol addiction causes severe problems, and its deprivation may potentiate symptoms such as anxiety. Furthermore, ethanol is a neurotoxic agent that induces degeneration and the consequences underlying alcohol-mediated brain damage remain unclear. This study assessed the behavioral changes during acute ethanol withdrawal periods and determined the levels of DNA damage and reactive oxygen species (ROS) in multiple brain areas. Male Wistar rats were subjected to an oral ethanol self-administration procedure with a forced diet where they were offered 8 % (v/v) ethanol solution for 21 days followed by five repeated 24-h cycles alternating between ethanol withdrawal and re-exposure. Control animals received an isocaloric control diet without ethanol. Behavioral changes were analyzed on ethanol withdrawal days in the open-field (OF) and elevated plus-maze (EPM) tests within the first 6 h of ethanol deprivation. The pre-frontal cortex, hypothalamus, striatum, hippocampus, and cerebellum were dissected for alkaline and neutral comet assays and for dichlorofluorescein ROS testing. The repeated intermittent ethanol access enhanced solution intake and alcohol-seeking behavior. Decreased exploratory activity was observed in the OF test, and the animals stretched less in the EPM test. DNA single-strand breaks and ROS production were significantly higher in all structures evaluated in the ethanol-treated rats compared with controls. The animal model of repeated intermittent ethanol access induced behavioral changes in rats, and this ethanol exposure model induced an increase in DNA single-strand breaks and ROS production in all brain areas. Our results suggest that these brain damages may influence future behaviors.
- Open Access
- 1 February 2013
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 51 (5) , 533-538
The association effect of insulin and clonazepam on oxidative stress in liver of an experimental animal model of diabetes and depression
Context: It is known that oxidative stress occurs in peripheral blood in an experimental animal model of diabetes and depression, and acute treatment with insulin and clonazepam (CNZ) has a protective effect on oxidative stress in this model. Objective: This study evaluated the effect of insulin plus CNZ on oxidative stress parameters in the liver of diabetic male rats induced with streptozotocin (STZ) and subjected to forced swimming test (FST). Materials and methods: Diabetes was induced by a single intraperitoneal (i.p.) dose of STZ 60 mg/kg in male Wistar rats. Insulin (4 IU/kg) plus CNZ acute i.p. treatment (0.25 mg/kg) was administered 24, 5 and 1 h before the FST. Nondiabetic control rats received i.p. injections of saline (1 mL/kg). Protein oxidative damage was evaluated by carbonyl formation and the antioxidant redox parameters were analyzed by the measurements of enzymatic activities of the superoxide dismutase (SOD), catalase and glyoxalase I (GLO). Glycemia levels also were determined. Results: Our present study has shown an increase in carbonyl content from diabetic rats subjected to FST (2.04 ± 0.55), while the activity of catalase (51.83 ± 19.02) and SOD (2.30 ± 1.23) were significantly decreased in liver from these animals, which were reverted by the treatment. Also, the activity of GLO (0.15 ± 0.02) in the liver of the animals was decreased. Discussion and conclusion: Our findings showed that insulin plus CNZ acute treatment ameliorate the antioxidant redox parameters and protect against protein oxidative damage in the liver of diabetic rats subjected to FST.
- 1 February 2013
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 51 (5) , 533-538
Open AccessThe association effect of insulin and clonazepam on oxidative stress in liver of an experimental animal model of diabetes and depression
Context: It is known that oxidative stress occurs in peripheral blood in an experimental animal model of diabetes and depression, and acute treatment with insulin and clonazepam (CNZ) has a protective effect on oxidative stress in this model. Objective: This study evaluated the effect of insulin plus CNZ on oxidative stress parameters in the liver of diabetic male rats induced with streptozotocin (STZ) and subjected to forced swimming test (FST). Materials and methods: Diabetes was induced by a single intraperitoneal (i.p.) dose of STZ 60 mg/kg in male Wistar rats. Insulin (4 IU/kg) plus CNZ acute i.p. treatment (0.25 mg/kg) was administered 24, 5 and 1 h before the FST. Nondiabetic control rats received i.p. injections of saline (1 mL/kg). Protein oxidative damage was evaluated by carbonyl formation and the antioxidant redox parameters were analyzed by the measurements of enzymatic activities of the superoxide dismutase (SOD), catalase and glyoxalase I (GLO). Glycemia levels also were determined. Results: Our present study has shown an increase in carbonyl content from diabetic rats subjected to FST (2.04 ± 0.55), while the activity of catalase (51.83 ± 19.02) and SOD (2.30 ± 1.23) were significantly decreased in liver from these animals, which were reverted by the treatment. Also, the activity of GLO (0.15 ± 0.02) in the liver of the animals was decreased. Discussion and conclusion: Our findings showed that insulin plus CNZ acute treatment ameliorate the antioxidant redox parameters and protect against protein oxidative damage in the liver of diabetic rats subjected to FST.